Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus

Neuron

Volumn 90, Issue 4, 2016, Pages 795-809

  Stempel, A Vanessa ^a,i   Stumpf, Alexander ^a   Zhang, Hai Ying ^b   Özdoğan, Tuğba ^a   Pannasch, Ulrike ^a   Theis, Anne Kathrin ^a   Otte, David Marian ^c   Wojtalla, Alexandra ^c   Rácz, Ildikó ^c   Ponomarenko, Alexey ^d,e   Xi, Zheng Xiong ^b   Zimmer, Andreas ^c   Schmitz, Dietmar ^a,d,f,g,h  

^a Neuroscience Research Center (NWFZ)   (Germany)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d Cluster of Excellence NeuroCure   (Germany)

^e LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^f BERNSTEIN CENTER FOR COMPUTATIONAL NEUROSCIENCE   (Germany)

^g GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^h Einstein Center for Neurosciences   (Germany)

ⁱ MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE SODIUM COTRANSPORTER; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; ENDOCANNABINOID; METABOTROPIC RECEPTOR;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GAMMA RHYTHM; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; MEMBRANE POTENTIAL; MOLECULAR BIOLOGY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; ANIMAL; LONG TERM DEPRESSION; METABOLISM; PHYSIOLOGY; SYNAPSE;

ACTION POTENTIALS; ANIMALS; CANNABINOID RECEPTOR MODULATORS; ENDOCANNABINOIDS; HIPPOCAMPUS; LONG-TERM SYNAPTIC DEPRESSION; MICE; NEURONAL PLASTICITY; PYRAMIDAL CELLS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84964583020     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.03.034     Document Type: Article

References (78)

1. Bacci A., Huguenard J.R., Prince D.A. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 2004, 431:312-316.
2. 2 receptor. J. Neurosci. Methods 2013, 216:87-95.
3. Bieri K.W., Bobbitt K.N., Colgin L.L. Slow and fast γ rhythms coordinate different spatial coding modes in hippocampal place cells. Neuron 2014, 82:670-681.
4. Bilkei-Gorzo A., Racz I., Valverde O., Otto M., Michel K., Sastre M., Zimmer A. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl. Acad. Sci. USA 2005, 102:15670-15675.
5. Bouaboula M., Bianchini L., McKenzie F.R., Pouyssegur J., Casellas P. Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways. FEBS Lett. 1999, 449:61-65.
6. Brenowitz S.D., Regehr W.G. Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 2005, 45:419-431.
7. Brusco A., Tagliaferro P., Saez T., Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 2008, 62:944-949.
8. Buckley N.E., McCoy K.L., Mezey E., Bonner T., Zimmer A., Felder C.C., Glass M., Zimmer A. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 2000, 396:141-149.
9. Buzsáki G., Wang X.-J. Mechanisms of gamma oscillations. Annu. Rev. Neurosci. 2012, 35:203-225.
10. Carta M., Lanore F., Rebola N., Szabo Z., Da Silva S.V., Lourenço J., Verraes A., Nadler A., Schultz C., Blanchet C., Mulle C. Membrane lipids tune synaptic transmission by direct modulation of presynaptic potassium channels. Neuron 2014, 81:787-799.
11. Castillo P.E., Younts T.J., Chávez A.E., Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron 2012, 76:70-81.
12. Chesler M., Kaila K. Modulation of pH by neuronal activity. Trends Neurosci. 1992, 15:396-402.
13. Chevaleyre V., Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 2003, 38:461-472.
14. Chevaleyre V., Castillo P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 2004, 43:871-881.
15. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 2006, 29:37-76.
16. Colgin L.L., Denninger T., Fyhn M., Hafting T., Bonnevie T., Jensen O., Moser M.-B., Moser E.I. Frequency of gamma oscillations routes flow of information in the hippocampus. Nature 2009, 462:353-357.
17. Csicsvari J., Jamieson B., Wise K.D., Buzsáki G. Mechanisms of gamma oscillations in the hippocampus of the behaving rat. Neuron 2003, 37:311-322.
18. den Boon F.S., Chameau P., Schaafsma-Zhao Q., van Aken W., Bari M., Oddi S., Kruse C.G., Maccarrone M., Wadman W.J., Werkman T.R. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc. Natl. Acad. Sci. USA 2012, 109:3534-3539.
19. Eckert W.A., Willcockson H.H., Light A.R. Interference of biocytin with opioid-evoked hyperpolarization and membrane properties of rat spinal substantia gelatinosa neurons. Neurosci. Lett. 2001, 297:117-120.
20. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 1995, 232:54-61.
21. García-Gutiérrez M.S., Ortega-Álvaro A., Busquets-García A., Pérez-Ortiz J.M., Caltana L., Ricatti M.J., Brusco A., Maldonado R., Manzanares J. Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. Neuropharmacology 2013, 73:388-396.
22. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 2002, 5:446-451.
23. Gong J.-P., Onaivi E.S., Ishiguro H., Liu Q.-R., Tagliaferro P.A., Brusco A., Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006, 1071:10-23.
24. Gustafsson B., Wigström H. Hyperpolarization following long-lasting tetanic activation of hippocampal pyramidal cells. Brain Res. 1983, 275:159-163.
25. Hájos N., Freund T.F. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids 2002, 121:73-82.
26. Hashimotodani Y., Ohno-Shosaku T., Maejima T., Fukami K., Kano M. Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. Neuropharmacology 2008, 54:58-67.
27. Ho B.Y., Uezono Y., Takada S., Takase I., Izumi F. Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels. Receptors Channels 1999, 6:363-374.
28. Jenniches I., Ternes S., Albayram O., Otte D.M., Bach K., Bindila L., Michel K., Lutz B., Bilkei-Gorzo A., Zimmer A. Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels. Biol. Psychiatry 2015, S0006-3223(15)00314-5. Published online April 14, 2015. 10.1016/j.biopsych.2015.03.033.
29. Kaczorowski C.C., Disterhoft J., Spruston N. Stability and plasticity of intrinsic membrane properties in hippocampal CA1 pyramidal neurons: effects of internal anions. J. Physiol. 2007, 578:799-818.
30. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
31. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 2012, 35:529-558.
32. Katona I., Sperlágh B., Sík A., Käfalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 1999, 19:4544-4558.
33. Kim J., Alger B.E. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat. Neurosci. 2010, 13:592-600.
34. Kim J., Li Y. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. J. Physiol. 2015, 593:871-886.
35. Kowalski J., Gan J., Jonas P., Pernía-Andrade A.J. Intrinsic membrane properties determine hippocampal differential firing pattern in vivo in anesthetized rats. Hippocampus 2015, Published online November 25, 2015. 10.1002/hipo.22550.
36. Kreitzer A.C., Carter A.G., Regehr W.G. Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 2002, 34:787-796.
37. Le Duigou C., Simonnet J., Teleñczuk M.T., Fricker D., Miles R. Recurrent synapses and circuits in the CA3 region of the hippocampus: an associative network. Front. Cell. Neurosci. 2014, 7:262.
38. Lee D., Lin B.-J., Lee A.K. Hippocampal place fields emerge upon single-cell manipulation of excitability during behavior. Science 2012, 337:849-853.
39. Li Y., Kim J. Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus. Neuroscience 2015, 311:253-267.
40. Li Y., Kim J. Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus. Hippocampus 2016, 26:275-281.
41. Li X., Rubio F.J., Zeric T., Bossert J.M., Kambhampati S., Cates H.M., Kennedy P.J., Liu Q.-R., Cimbro R., Hope B.T., et al. Incubation of methamphetamine craving is associated with selective increases in expression of Bdnf and trkb, glutamate receptors, and epigenetic enzymes in cue-activated fos-expressing dorsal striatal neurons. J. Neurosci. 2015, 35:8232-8244.
42. Liu Q.-R., Pan C.-H., Hishimoto A., Li C.-Y., Xi Z.-X., Llorente-Berzal A., Viveros M.-P., Ishiguro H., Arinami T., Onaivi E.S., Uhl G.R. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav. 2009, 8:519-530.
43. Liu Q.-R., Rubio F.J., Bossert J.M., Marchant N.J., Fanous S., Hou X., Shaham Y., Hope B.T. Detection of molecular alterations in methamphetamine-activated Fos-expressing neurons from a single rat dorsal striatum using fluorescence-activated cell sorting (FACS). J. Neurochem. 2014, 128:173-185.
44. Lodge D., Tidball P., Mercier M.S., Lucas S.J., Hanna L., Ceolin L., Kritikos M., Fitzjohn S.M., Sherwood J.L., Bannister N., et al. Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors. Neuropharmacology 2013, 74:135-146.
45. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 1995, 15:6552-6561.
46. Maier N., Tejero-Cantero A., Dorrn A.L., Winterer J., Beed P.S., Morris G., Kempter R., Poulet J.F.A., Leibold C., Schmitz D. Coherent phasic excitation during hippocampal ripples. Neuron 2011, 72:137-152.
47. Maier N., Morris G., Schuchmann S., Korotkova T., Ponomarenko A., Böhm C., Wozny C., Schmitz D. Cannabinoids disrupt hippocampal sharp wave-ripples via inhibition of glutamate release. Hippocampus 2012, 22:1350-1362.
48. Majumdar D., Maunsbach A.B., Shacka J.J., Williams J.B., Berger U.V., Schultz K.P., Harkins L.E., Boron W.F., Roth K.A., Bevensee M.O. Localization of electrogenic Na/bicarbonate cotransporter NBCe1 variants in rat brain. Neuroscience 2008, 155:818-832.
49. Marchalant Y., Brownjohn P.W., Bonnet A., Kleffmann T., Ashton J.C. Validating antibodies to the cannabinoid CB2 receptor: Antibody sensitivity is not evidence of antibody specificity. J. Histochem. Cytochem. 2014, 62:395-404.
50. Marinelli S., Pacioni S., Cannich A., Marsicano G., Bacci A. Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat. Neurosci. 2009, 12:1488-1490.
51. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., van der Stelt M., et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
52. Monory K., Massa F., Egertová M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006, 51:455-466.
53. Morgan N.H., Stanford I.M., Woodhall G.L. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 2009, 57:356-368.
54. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
55. Onaivi E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006, 54:231-246.
56. Onaivi E.S. Commentary: Functional neuronal CB2 cannabinoid receptors in the CNS. Curr. Neuropharmacol. 2011, 9:205-208.
57. Palmer M.J., Irving A.J., Seabrook G.R., Jane D.E., Collingridge G.L. The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus. Neuropharmacology 1997, 36:1517-1532.
58. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 2002, 99:8384-8388.
59. Robbe D., Montgomery S.M., Thome A., Rueda-Orozco P.E., McNaughton B.L., Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat. Neurosci. 2006, 9:1526-1533.
60. Ruffin V.A., Salameh A.I., Boron W.F., Parker M.D. Intracellular pH regulation by acid-base transporters in mammalian neurons. Front. Physiol. 2014, 5:43.
61. Salter M.W., Beggs S. Sublime microglia: expanding roles for the guardians of the CNS. Cell 2014, 158:15-24.
62. Schmöle A.-C., Lundt R., Gennequin B., Schrage H., Beins E., Krämer A., Zimmer T., Limmer A., Zimmer A., Otte D.-M. Expression Analysis of CB2-GFP BAC Transgenic Mice. PLoS ONE 2015, 10:e0138986.
63. Schomburg E.W., Fernández-Ruiz A., Mizuseki K., Berényi A., Anastassiou C.A., Koch C., Buzsáki G. Theta phase segregation of input-specific gamma patterns in entorhinal-hippocampal networks. Neuron 2014, 84:470-485.
64. Sloviter R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1991, 1:41-66.
65. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
66. Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66:173-192.
67. Takahashi K.A., Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 2006, 139:795-802.
68. Tropp Sneider J., Chrobak J.J., Quirk M.C., Oler J.A., Markus E.J. Differential behavioral state-dependence in the burst properties of CA3 and CA1 neurons. Neuroscience 2006, 141:1665-1677.
69. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
70. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
71. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
72. Wittner L., Miles R. Factors defining a pacemaker region for synchrony in the hippocampus. J. Physiol. 2007, 584:867-883.
73. Wulff P., Ponomarenko A.A., Bartos M., Korotkova T.M., Fuchs E.C., Bähner F., Both M., Tort A.B.L., Kopell N.J., Wisden W., Monyer H. Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons. Proc. Natl. Acad. Sci. USA 2009, 106:3561-3566.
74. 2 receptors modulate cocaine's actions in mice. Nat. Neurosci. 2011, 14:1160-1166.
75. Young S.R., Chuang S.-C., Zhao W., Wong R.K.S., Bianchi R. Persistent receptor activity underlies group I mGluR-mediated cellular plasticity in CA3 neuron. J. Neurosci. 2013, 33:2526-2540.
76. Younts T.J., Chevaleyre V., Castillo P.E. CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. J. Neurosci. 2013, 33:13743-13757.
77. Zhang H.-Y., Gao M., Liu Q.-R., Bi G.-H., Li X., Yang H.-J., Gardner E.L., Wu J., Xi Z.-X. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc. Natl. Acad. Sci. USA 2014, 111:E5007-E5015.
78. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999, 96:5780-5785.